Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2630 |
|
Actual shortage: | 254 (10%) | |
Anticipated shortage: | 2 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2365 (90%) | |
Discontinuation Reports |
249 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 246 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
318 (11%) |
|
Overdue reports |
22 (8%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144752 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2021-08-27 | 2021-09-16 | 144721 |
TEVA-BUPRENORPHINE/NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144704 |
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2021-03-25 | 2021-09-16 | 136283 |
ACT ENALAPRIL | 8MG | TABLET | Resolved | 2021-02-25 | 2021-09-16 | 134743 |
TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2021-06-10 | 2021-09-10 | 140681 |
TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-12-19 | 2021-09-10 | 101725 |
TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2019-12-05 | 2021-09-10 | 100305 |
TEVA-IRBESARTAN | 300MG | TABLET | Resolved | 2019-07-02 | 2021-09-10 | 88171 |
TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2019-09-19 | 2021-09-10 | 94369 |
TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2021-09-02 | 2021-09-09 | 145109 |
TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2021-08-05 | 2021-09-09 | 143719 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-07-29 | 2021-09-09 | 143250 |
TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2021-07-15 | 2021-09-09 | 142616 |
TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-07-15 | 2021-09-09 | 142610 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2021-08-05 | 2021-09-09 | 143734 |
TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2021-08-05 | 2021-09-09 | 143731 |
TEVA-BROMAZEPAM | 3MG | TABLET | Resolved | 2021-07-08 | 2021-09-09 | 142192 |
ACT ENALAPRIL | 4MG | TABLET | Resolved | 2021-04-08 | 2021-09-09 | 137203 |
TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-05 | 2021-09-02 | 143722 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT ZOPICLONE | 5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65191 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |